Entera Bio Reports Q3 2024 Financial Results And Provides Business Updates
Entera Bio Ltd. (NASDAQ: ENTX), (“Entera” or the“Company”) a leader in the development of oral peptides and small therapeutic proteins, today reported financial results and key business updates for ...
Futurefuel Releases Third Quarter 2024 Results
Reports Net Loss of $1.2 Million or $0.03 per Diluted Share, and Adjusted EBITDA of $(1.0) MillionCLAYTON, Mo., Nov. 08, 2024 (GLOBE NEWSWI ...